Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts. Show more

Location: 300 5th Avenue, Waltham, MA, 02451, United States | Website: https://crescentbiopharma.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

183.8M

52 Wk Range

$10.83 - $63.00

Previous Close

$13.23

Open

$13.21

Volume

64,224

Day Range

$13.01 - $13.80

Enterprise Value

36.8M

Cash

152.6M

Avg Qtr Burn

-6.269M

Insider Ownership

6.62%

Institutional Own.

77.39%

Qtr Updated

06/30/25